FDA NDC Directory · JSON-LD · Markdown

Prevalite

NDC 0245-0036 · HUMAN PRESCRIPTION DRUG · POWDER, FOR SUSPENSION

Generic namecholestyramine
Labeler / ManufacturerUpsher-Smith Laboratories, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA073263
Dosage form / routePOWDER, FOR SUSPENSION · ORAL
Active ingredientsCHOLESTYRAMINE (4 g/5.5g)
Marketing started19960201
Marketing ended20271031
Package count3

External sources

Source: openFDA. Public-domain (CC0).